Index of artpub/2017/pmc_28899363/

Reynolds, Kerry Lynn
A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer
2017
https://ddd.uab.cat/record/186327